Spero Health Virginia Core Lab

CLIA Laboratory Citation Details

2
Total Citations
5
Total Deficiencyies
4
Unique D-Tags
CMS Certification Number 49D2257480
Address 5631 S Laburnam Ave, Richmond, VA, 23231
City Richmond
State VA
Zip Code23231
Phone615 265-0374
Lab DirectorSTANLEY WU

Citation History (2 surveys)

Survey - June 9, 2026

Survey Type: Standard

Survey Event ID: XZYR11

Deficiency Tags: D0000 D5433

Summary:

Summary Statement of Deficiencies D0000 An announced CLIA recertification survey was conducted at Spero Health Virginia Core Lab on June 9, 2026 by the Virginia Department of Health's Office of Licensure and Certification. The laboratory was surveyed under 42 CFR part 493 CLIA Regulations. Spero Health Virginia Core Lab was not in compliance with the applicable Conditions and Standards under 42 CFR part 493 CLIA Regulations. Specific deficiencies are as follows: D5433 MAINTENANCE AND FUNCTION CHECKS CFR(s): 493.1254(b)(1) (b)(1)(i) Establish a maintenance protocol that ensures equipment, instrument, and test system performance that is necessary for accurate and reliable test results and test result reporting. (b)(1)(ii) Perform and document the maintenance activities specified in paragraph b(1)(i) of this section. This STANDARD is not met as evidenced by: Based on a laboratory tour, review of Instrument logs, Quality Control (QC) records and interview, the laboratory failed to follow their established process to record incubator temperature and pressures for the Mass Spectrometer on twenty-seven (27) testing days in calendar year 2025. Findings include: 1. During an initial laboratory tour with the lab manager on 6/09/26 at 9:15 am, it was revealed the laboratory utilizes the AB Sciex Triple Quad 4500 Mass Spectrometer (ABSX1) for high complexity drug testing. 2. A review of lab's Daily LC-MSMS Instrument log revealed the laboratory records ABSX1 Nitrogen Pressure, Incubator temp, Pump A & B pressures each day of testing. 3. A review of the 2025 QC records for the ABSX1 and the corresponding 2025 instrument logs revealed the lab failed to document daily maintenance on the following 27 dates in 2025: January 13, 15, 19; February 7, 19; March 17, 23; April 23, 28; May 2, 12, 21; June 13; July 3, 10, 16; August 4, 14, 29; September 10, 22, 24, 29; October 7, 15; November 30; and December 10. 4. In an interview with the lab manager at 4:30 pm, it was explained that maintenance is Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- performed each morning. QC is ordered in their information system, specimens spiked, run and evaluated each day of patient testing on the Mass Spectometer. QC is not run if there are no patients. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - September 6, 2024

Survey Type: Standard

Survey Event ID: SOD811

Deficiency Tags: D0000 D5211 D5439

Summary:

Summary Statement of Deficiencies D0000 An announced CLIA Recertification survey was conducted at the Spero Health Virginia Core Lab on September 5 & 6, 2024 by the Virginia Department of Health's Office of Licensure and Certification. The laboratory was surveyed under 42 CFR part 493 CLIA Requirements. Specific deficiencies cited are as follows: D5211 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(a) The laboratory must review and evaluate the results obtained on proficiency testing performed as specified in subpart H of this part. This STANDARD is not met as evidenced by: Based on the review of the policy and procedure (P&P), lab test menu, proficiency testing records (PT), lack of documentation, and interviews, the laboratory failed to review and sign the PT results for 47 of 47 urine toxicology analytes for seven of ten events in 2023 and 2024. Findings include: 1. Review of the policy "Proficiency Testing and Employee Competency" revealed the following statement, "The results will be reviewed by the lab director and/or designee, and any failed results will be investigated, and

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access